Dow Up0.51% Nasdaq Up0.24%

GW Pharmaceuticals plc (GWPH)

78.95 Up 0.03(0.04%) Nov 21, 4:00PM EST
ProfileGet Profile for:
GW Pharmaceuticals plc
Porton Down Science Park
Salisbury, SP4 0JQ
United Kingdom - Map
Phone: 44 19 8055 7000
Fax: 44 19 8055 7111

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:214

Business Summary 

GW Pharmaceuticals plc, a biopharmaceutical company, together with its subsidiaries, is engaged in discovering, developing, and commercializing cannabinoid prescription medicines. The company operates through three segments: Sativex Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. In addition, the company’s product pipeline includes an orphan childhood epilepsy program, as well as other product candidates in Phase I and II clinical development for the treatment of glioma, ulcerative colitis, type-2 diabetes, and schizophrenia. It has a strategic alliance with Otsuka Pharmaceutical Co., Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on GW Pharmaceuticals plc

Key Executives 
Dr. Geoffrey W. Guy BSc, MB BS, MRCS Eng, LRCP, LMSSA. Dip Pharm Med, 59
Founder, Exec. Chairman and Chairman of Nominations Committee
Mr. Justin D. Gover BSc,MBA, 43
Chief Exec. Officer, Managing Director and Exec. Director
Mr. Adam David George BSc, ACA, 44
Chief Financial Officer, Principal Accounting Officer, Company Sec. and Exec. Director
Mr. Christopher John Tovey BSc, 48
Chief Operating Officer and Exec. Director
Dr. Stephen Wright MA, M.D., FRCP (Edin), FFPM., 62
R&D Director and Exec. Director
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.